ArticleFrontiers in medicine2025
Visual outcomes and spectacle independence of a non-diffractive wavefront-shaping intraocular lens in post-LASIK patients.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To compare visual outcomes, depth of field (DOF), spectacle independence, and patient satisfaction of cataract patients with and without previous myopic laser in situ keratomileusis (LASIK) surgery who received a non-diffractive extended range-of-focus (EROF) intraocular lens (IOL). Setting: Xiamen Eye Center, Xiamen, China. Design: Prospective case series. Methods: A total of 50 eyes of 41 patients implanted with the Vivity IOL were divided into Post-LASIK and Virgin groups. Outcome measures included uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), uncorrected intermediate visual acuity (UIVA), uncorrected near visual acuity (UNVA), refractive outcomes, defocus curves, subjective DOF, spectacle independence, and Visual Function questionnaire (VF-14) after 3 months postoperatively. Results: Postoperatively, 70% of the Post-LASIK and 86.7% of the Virgin group had refractive error within ± 0.50 D ( Conclusion: In post-LASIK eyes, this wavefront-shaping EROF IOL was well-tolerated and provided an extended range of vision with significantly better UNVA, fewer difficulties in daily activities and higher spectacle independence for near vision compared to normal eyes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.